Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Eribulin in Korean Breast Cancer Participants

View source ↗

Summary

This clinical trial update concerns a study evaluating the efficacy and safety of eribulin in Korean participants with locally advanced or metastatic breast can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Halaven (eribulin)

Snippet

Sponsor: Eisai Korea Inc. | Conditions: Locally Advanced or Metastatic Breast Cancer | Status: COMPLETED